Graphene-Based Devices Face Regulation Questions In Europe

Medtech Insight spoke to two CEOs of start-ups working on graphene-based devices to learn more about how regulation and fears over nanomaterials’ side effects affect device development.

• Source: Alamy

New companies have been attempting to exploit graphene’s properties for medtech because it offers unrivalled conductivity at body temperature, flexibility, and most importantly, biocompatibility.

Since first being isolated by professors Andre Geim and Kostya Novoselov in 2004 at the University of Manchester, graphene has been used in a wide range of

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diagnostics

More from Device Area